IN2014DN10043A - - Google Patents
Info
- Publication number
- IN2014DN10043A IN2014DN10043A IN10043DEN2014A IN2014DN10043A IN 2014DN10043 A IN2014DN10043 A IN 2014DN10043A IN 10043DEN2014 A IN10043DEN2014 A IN 10043DEN2014A IN 2014DN10043 A IN2014DN10043 A IN 2014DN10043A
- Authority
- IN
- India
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/145—Clostridium
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2012901658A AU2012901658A0 (en) | 2012-04-27 | Compositions and methods of use | |
| PCT/AU2013/000439 WO2013159155A1 (en) | 2012-04-27 | 2013-04-29 | Oncolytic clostridium ghonii strains, and methods of production and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN10043A true IN2014DN10043A (en) | 2015-08-14 |
Family
ID=49460371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN10043DEN2014 IN2014DN10043A (en) | 2012-04-27 | 2014-11-27 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9962412B2 (en) |
| EP (1) | EP2841558B1 (en) |
| CN (2) | CN103374538B (en) |
| AU (1) | AU2013252495B2 (en) |
| IN (1) | IN2014DN10043A (en) |
| RU (1) | RU2667432C2 (en) |
| WO (1) | WO2013159155A1 (en) |
| ZA (1) | ZA201408690B (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103374538B (en) * | 2012-04-27 | 2017-12-01 | 山东新创生物科技有限公司 | The composition and its application method of derivative bacterium bacterial strain comprising Clostridium ghonii (Clostridiumghonii) |
| CN104473973B (en) * | 2014-12-19 | 2015-08-05 | 山东创新药物研发有限公司 | The application of one strain Clostridium ghonii domestication strain |
| CN106868024B (en) * | 2017-04-01 | 2020-03-17 | 山东新创生物科技有限公司 | Clostridium goeri specific PCR detection primer and method |
| CA3069523A1 (en) | 2017-07-11 | 2019-01-17 | Actym Therapeutics, Inc. | Engineered immunostimulatory bacterial strains and uses thereof |
| KR20210030973A (en) | 2018-07-11 | 2021-03-18 | 액팀 테라퓨틱스, 인코퍼레이티드 | Engineered immunostimulatory bacterial strains and uses thereof |
| EP3844276A2 (en) | 2018-08-28 | 2021-07-07 | Actym Therapeutics, Inc. | Engineered immunostimulatory bacterial strains and uses thereof |
| CA3131017A1 (en) | 2019-02-27 | 2020-09-03 | Actym Therapeutics, Inc. | Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironment |
| IL292836A (en) | 2019-11-12 | 2022-07-01 | Actym Therapeutics Inc | Immunostimulatory bacteria delivery platforms and their use for delivery of therapeutic products |
| EP4077359A1 (en) | 2019-12-18 | 2022-10-26 | Exomnis Biotech B.V. | Genetically modified clostridium strains and uses thereof |
| CA3191433A1 (en) | 2020-08-12 | 2022-02-17 | Actym Therapeutics, Inc. | Immunostimulatory bacteria-based vaccines, therapeutics, and rna delivery platforms |
| CN113855710B (en) * | 2021-10-09 | 2024-02-20 | 施慧达药业集团(吉林)有限公司 | Application of clostridium gossypii combined tumor angiogenesis inhibitor |
| CN115569193B (en) * | 2021-10-09 | 2024-04-02 | 施慧达药业集团(吉林)有限公司 | Application of clostridium gossypii spores combined with palbociclib monoclonal antibody and preparation method of drug for treating colon cancer and clostridium gossypii spore freeze-dried powder |
| WO2023086796A2 (en) | 2021-11-09 | 2023-05-19 | Actym Therapeutics, Inc. | Immunostimulatory bacteria for converting macrophages into a phenotype amenable to treatment, and companion diagnostic for identifying subjects for treatment |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1069144A (en) * | 1963-07-10 | 1967-05-17 | Merck & Co Inc | Method for the treatment of malignant tumors |
| AUPQ899700A0 (en) * | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
| US20060134140A1 (en) * | 2001-04-12 | 2006-06-22 | Dana Lasko | Compositions and methods for treating tumor spreading |
| WO2011002824A1 (en) * | 2009-06-29 | 2011-01-06 | Qteros, Inc. | Pretreatment of biomass |
| CN103374538B (en) * | 2012-04-27 | 2017-12-01 | 山东新创生物科技有限公司 | The composition and its application method of derivative bacterium bacterial strain comprising Clostridium ghonii (Clostridiumghonii) |
| CN104473973B (en) * | 2014-12-19 | 2015-08-05 | 山东创新药物研发有限公司 | The application of one strain Clostridium ghonii domestication strain |
-
2012
- 2012-08-28 CN CN201210310374.4A patent/CN103374538B/en active Active
- 2012-08-28 CN CN201711093258.0A patent/CN108102945B/en active Active
-
2013
- 2013-04-29 RU RU2014147735A patent/RU2667432C2/en active
- 2013-04-29 WO PCT/AU2013/000439 patent/WO2013159155A1/en active Application Filing
- 2013-04-29 US US14/397,293 patent/US9962412B2/en active Active
- 2013-04-29 AU AU2013252495A patent/AU2013252495B2/en active Active
- 2013-04-29 EP EP13780960.4A patent/EP2841558B1/en active Active
-
2014
- 2014-11-26 ZA ZA2014/08690A patent/ZA201408690B/en unknown
- 2014-11-27 IN IN10043DEN2014 patent/IN2014DN10043A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN103374538B (en) | 2017-12-01 |
| RU2667432C2 (en) | 2018-09-19 |
| EP2841558B1 (en) | 2018-03-21 |
| RU2014147735A (en) | 2016-06-20 |
| AU2013252495A1 (en) | 2014-12-18 |
| AU2013252495B2 (en) | 2018-12-13 |
| CN108102945B (en) | 2021-08-24 |
| US9962412B2 (en) | 2018-05-08 |
| ZA201408690B (en) | 2016-03-30 |
| CN108102945A (en) | 2018-06-01 |
| EP2841558A1 (en) | 2015-03-04 |
| US20150147315A1 (en) | 2015-05-28 |
| WO2013159155A1 (en) | 2013-10-31 |
| EP2841558A4 (en) | 2015-11-04 |
| CN103374538A (en) | 2013-10-30 |